Altamira Therapeutics Ltd.: xbrl:AdditionsToRightofuseAssets

Value{"amount": 594436, "currency": "USD"}
Period2021-01-01 – 2021-12-31
Statussuperseded
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-22-019292
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/73caa497-2a96-4cc4-9bb0-1345830ee971

History